Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase. - Suppr | 超能文献

Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase.

作者信息

Nicosia S, Spada A, Borghi C, Cortelazzi L, Giannattasio G

出版信息

FEBS Lett. 1980 Apr 7;112(2):159-62. doi: 10.1016/0014-5793(80)80170-0.

DOI:10.1016/0014-5793(80)80170-0

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase.

FEBS Lett. 1980 Apr 7;112(2):159-62. doi: 10.1016/0014-5793(80)80170-0.

2

VIP stimulates ACTH release and adenylate cyclase in human ACTH-secreting pituitary adenomas.血管活性肠肽可刺激人促肾上腺皮质激素分泌性垂体腺瘤释放促肾上腺皮质激素及激活腺苷酸环化酶。

Eur J Pharmacol. 1982 Sep 10;83(1-2):101-5. doi: 10.1016/0014-2999(82)90291-6.

3

[Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].[血管活性肠肽（VIP）：人催乳素分泌型垂体瘤中的特异性受体与腺苷酸环化酶激活]

C R Seances Acad Sci D. 1979 May 7;288(17):1315-7.

4

Adenylate cyclase of rat pituitary gland: stimulation by vasoactive intestinal polypeptide (VIP).大鼠垂体腺苷酸环化酶：血管活性肠肽（VIP）的刺激作用。

FEBS Lett. 1979 Dec 15;108(2):403-6. doi: 10.1016/0014-5793(79)80573-6.

5

A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.

Neuroendocrinology. 1990 Apr;51(4):481-6. doi: 10.1159/000125378.

6

VIP activation of rat anterior pituitary adenylate cyclase.血管活性肠肽对大鼠垂体前叶腺苷酸环化酶的激活作用。

FEBS Lett. 1979 Jul 15;103(2):229-33. doi: 10.1016/0014-5793(79)81333-2.

7

In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide.人泌乳素分泌型垂体腺瘤中泌乳素释放及腺苷酸环化酶活性的体外研究。大腺瘤和微腺瘤对多巴胺及血管活性肠肽的不同敏感性。

J Clin Endocrinol Metab. 1983 Jan;56(1):1-10. doi: 10.1210/jcem-56-1-1.

8

Combined effects of vasoactive intestinal peptide and dopamine on adenylate cyclase in prolactin-secreting cells.血管活性肠肽与多巴胺对催乳素分泌细胞中腺苷酸环化酶的联合作用

Peptides. 1984 Nov-Dec;5(6):1067-70. doi: 10.1016/0196-9781(84)90172-4.

9

Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi.蛋白激酶C通过使抑制性GTP结合蛋白Gi失活，刺激分泌催乳素的大鼠腺瘤（GH4C1）垂体细胞中的腺苷酸环化酶活性。

Eur J Biochem. 1989 Aug 1;183(2):397-406. doi: 10.1111/j.1432-1033.1989.tb14941.x.

10

Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.血管活性肠肽（VIP）对人垂体腺瘤细胞培养物中生长激素（GH）和催乳素（PRL）释放及细胞形态的影响。

Folia Histochem Cytobiol. 2000;38(3):119-27.

引用本文的文献

1

The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone.血管活性肠肽（VIP）作为一种下丘脑神经激素的作用。

J Endocrinol Invest. 1983 Jun;6(3):235-42. doi: 10.1007/BF03350614.

2

Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.人垂体腺及腺瘤中的血管活性肠肽。一项免疫细胞化学研究。

Am J Pathol. 1989 Aug;135(2):329-38.

3

Hyperprolactinemia: neuroendocrine and diagnostic aspects.高催乳素血症：神经内分泌及诊断方面

J Endocrinol Invest. 1989 Oct;12(9):653-68. doi: 10.1007/BF03350030.